Key facts
- This page summarizes Lynnette C. Fallon's Form 4 filing for ClearPoint Neuro, Inc. (CLPT).
- 1 reported transaction and 1 derivative row are listed below.
- Accepted by SEC: 26 May 2026, 16:30.
Key filing fact
Ownership activity is grounded in SEC Form 4 disclosures.
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
Award
Additional SEC filing notes
Footnote F1
Each restricted stock unit represents a contingent right to receive one share of CLPT common stock.
Footnote F2
The restricted stock units vest on the earlier of (i) the first anniversary of the grant date, or (ii) the day immediately preceding the Company's 2027 annual meeting of stockholders.